Changes to This Summary (11/04/2011)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

Intervention ¹

Added text ² about the American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer [cited Rizzo et al. as reference 24; Medication Guide: Aranesp (darbepoetin alfa) as reference 25; Procrit Label and Epogen Label as reference 26; and Aranesp (darbepoetin alfa) Label as reference 27].

Added text ³ about a review and meta-analysis of randomized and open-label studies of erythropoiesis-stimulating agents.